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Multidisciplinary research priorities for the COVID-19 pandemic: authors’ reply 
 
We welcome the commentary that our COVID-19 Mental Health Science Position 
Paper has ignited. Together, these responses highlight the importance of many 
different perspectives and the wide range of voices that are necessary to navigate 
the mental health challenges of the pandemic.  We are encouraged and stimulated 
by the recent correspondence published in the July issue of Lancet Psychiatry. Some 
key messages were consistent across the correspondence; namely, that the mental 
health impacts of COVID-19 are likely to be profound, long lasting, and will touch all 
sectors of society.  There was also consensus that only by harnessing a truly 
multidisciplinary response will we be able to mitigate the mental health risks 
effectively. How best to do this will be a challenge that requires most of us to think 
and work differently, and for our scientific, research and practice communities to 
come together to create novel solutions.  
 
In writing our Position Paper the aim was to galvanise the mental health science 
community in pursuing a coordinated response of high quality research with robust 
ethical standards that prioritised near term utility for mental health.  To achieve this 
we rapidly synthesised views from a range of backgrounds along with more than 
3,000 survey responses from the public and people with lived experience of mental 
ill-health.  Our approach to patient and public engagement was noted in a recent 
blog from the Nuffield Council on Bioethics1.   
 
We set out immediate research priorities and longer-term strategies into the 
psychological, social and neuroscientific effects of COVID-19.   The extant priorities 
represent the collective views of the author team and our respective biases, working 
at speed at the start of the pandemic. We sought to highlight some vulnerable 
groups who will need research attention, and recognise how important it is to 
ensure all affected groups are made more visible (see letters in this July issue). 
Further and emerging vulnerabilities may manifest as events unfold and priorities 
should be reviewed as the pandemic evolves. The recent correspondence 
complements the priorities outlined in the Position Paper and will stimulate further 
research employing diverse methods, including more perspectives from social 
sciences and focusing on additional vulnerable populations (e.g., young people with 
complex forensic mental health needs, Hales et al., this issue). 
 
It is still too early to say what the medium and longer-term impact of COVID-19 on 
mental health and wellbeing will be.  However, the intention to highlight the 
profound effect on mental health for some is supported by a Royal College of 
Psychiatrists survey in early May 2020 that found 43% of clinicians were seeing an 
increase in urgent and emergency cases, including those who are suicidal or self-
harming2. The concern among many is that as we emerge from lockdown, the 
economic and social consequences of the pandemic will take hold, and diverse and 
damaging mental health impacts and disparities may escalate further.  We also must 
ensure that research focused on protecting those working at the frontline of the 
pandemic, including the health and social care workforce, is prioritised.  
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In terms of the public discourse around the pandemic, the message in the UK – and 
North America as well – is that “we are all in this together” but such statements are 
not supported by the statistics. The virus itself affects groups of people differentially; 
mortality rates are socially patterned, with deaths being more common among the 
over 70s, members of Black, Asian and Minority Ethnic communities, and those who 
are most socially disadvantaged.   When describing the consequences of COVID-19, 
as the writer Damian Barr wrote on Twitter recently, it is more accurate to say that 
although we are all navigating the same Coronavirus storm, we are in different types 
of boats: some people are in super-yachts and others have only a single oar.  Those 
in the most affected boats are also more likely to be exposed to a clustering of 
socially structured disadvantage across generations resulting in increased morbidity 
and mortality from COVID-19. It is vital, therefore, that research into the mental 
health effects of social and welfare policies and structural inequality is prioritised 
(Morgan & Rose, this issue).  We must all challenge the social and economic 
inequalities that contribute to poor mental health3. To address health paradoxes, 
history suggests we need to seek innovations to our existing approaches4. Mental 
health science must embrace the full range of scales at which initiatives can be 
targeted (i.e., societal, community as well as individual targets). We must consider 
mechanisms of change at all levels, irrespective of whether these are public health 
interventions, individual approaches or global initiatives. To achieve this, we need to 
find new ways to bring research communities together, because mental health 
science is best served when we join forces, complementing each other. Diversity will 
be our strength, and it is only through working together across disciplines that we 
will tackle the global challenge of COVID-19.  
 
The correspondents raised a number of points that, although included in the Position 
Paper, are important to emphasise. First, co-design should be integral to everything 
done as part of the mental health science response; it is critical that those affected 
by COVID-19 and those with mental health problems have a voice. For example, 
young people should be included as equal partners in the design and 
implementation of mental health science solutions for them. Such collaboration will 
enrich the research process and may also lead to the inclusion of novel aspects of 
positive mental health such as resilience, courage and compassion (Singh et al., this 
volume).  Second, research into the COVID-19 pandemic should ensure that Black, 
Asian and Minority Ethnic communities are represented (both as participants in co-
design and on study management groups), indeed we welcome the call for a race 
equality impact assessment being applied to all forthcoming research studies (Smith 
et al., 2020, this issue). Research into the link between ethnicity and COVID-19 
outcome is urgent5 and mental health aspects need to be included here.  To 
effectively identify the impact of the virus and interventions on different 
communities, such representation must be sufficiently granular and recognise the 
intersectionality of risks.  Third, in the rush to understand the impact of COVID-19 on 
mental health and wellbeing, it is more important than ever that the highest 
standards of ethical research practice are maintained. Such standards include 
respecting confidentiality and recognising potential harms as well as focusing on 
issues around acceptability (of potential interventions) and trustworthiness (in terms 
of data collection and data sharing; Singh et al., this issue).  Townsend et al.6 have 
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published some useful guidance in this regard.  For example, they recommend mood 
measurements, mood mitigation techniques as standard and stress the importance 
of conducting research that has clear benefits while keeping the risks low.    
 
Fourth, the mental health science response must be truly multidisciplinary in 
implementation. In the Paper, we highlighted a wide range of disciplines and the 
original author group was drawn from diverse disciplinary backgrounds.  However, 
many further professions need to be included, for example nursing is central to the 
COVID-19 research response (Brennan, 2020, this issue).  Just under 40,000 mental 
health nurses make-up the largest component of the UK NHS psychiatric workforce 
and it is essential that mental health nurse researchers are included to ensure that 
any research is responsive to their concerns and priorities.  Fifth, we also recognise 
that feeling distressed or anxious is understandable for many going through such 
unprecedented times (Siddaway, 2020, this issue). It is therefore important that any 
mental health response is commensurate and tailored. Clearly, for those who are 
vulnerable, it is important to be vigilant to mitigate the risks to mental health 
difficulties.  We also need to consider longer term preventive approaches more 
broadly so that we are more responsive to the chronic consequences of the current 
pandemic as well as being better prepared for future public health crises.   
 
The Position Paper was pitched as a call for action and we warmly thank the 
correspondents for their energetic response which helps increase breadth and 
inclusion in the mental health research response to COVID-19. This is not only an 
important reminder to funding agencies but an even stronger incentive to advance 
the mobilisation and coordination of the whole community of mental health 
scholars. It has already provided a welcome platform for starting dialogue with 
researchers, research funders and the wider mental health science community, and 
a continued conversation is necessary. It is now a responsibility to include the voices 
of all those whose mental health is impacted by this pandemic and ensure that 
research findings are translated into practice.  
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